🇺🇸 FDA
Patent

US 12145939

Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators

granted A61PA61P25/00

Quick answer

US patent 12145939 (Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators) held by PRAXIS PRECISION MEDICINES, INC. expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRAXIS PRECISION MEDICINES, INC.
Grant date
Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P25/00